Distinctive Ideas
Pooling global perspectives, forging ahead with unique insights.
MBMC Quick Report: UBTECH Robotics completed its IPO plus three placings, with a total of 5.8% of shares issued and nearly HK$2.2 billion raised, and it has been listed in Hong Kong for less than a year.
UBTECH (09880.HK) recently issued an announcement, stating that the company intends to place 7 million new H shares at a price of HK$83.88 per share, with the gross proceeds amounting to approximately HK$587.16 million. After deducting relevant costs and expenses, the net proceeds will be approximately HK$551.88 million.
MBMC Breaking News: Pony.ai launches IPO subscription for its US listing, with a potential valuation of up to 34.9 billion US dollars
Chinese mainland autonomous driving startup Pony.ai has launched its IPO listing process in the United States, with a valuation of up to US$4.48 billion (approximately HK$34.944 billion).
MBMC Breaking News: Trump is reportedly considering appointing a lawyer as the new SEC Chairman.
Bloomberg quoted sources as reporting that partners Richard Farley of Kramer Levin Naftalis & Frankel LLP, Norm Champ of Kirkland & Ellis LLP, and others are among the potential candidates to succeed Gary Gensler as Chairman of the U.S. Securities and Exchange Commission (SEC).
MBMC Quick Report: Haomo.AI may go public in Hong Kong in 2025
According to Daily Economic News, regarding the recent news that Wei Jianjun, chairman of Great Wall Motors (02333.HK), had temporarily suspended Haomo Zhixing's Hong Kong IPO plan internally, Zhang Kai, chairman of Haomo Zhixing, told Daily Economic News in a recent interview, "Currently, Haomo Zhixing has not suspended its plan for a Hong Kong IPO, and the process is still ongoing."
MBMC Breaking News: The first SPAC merger transaction on the Hong Kong Stock Exchange will be listed in Hong Kong on October 30, with Alibaba as its single largest shareholder.
Virtue Acquisition (07841.HK), a special purpose acquisition company (SPAC for short) launched by former Chief Executive of the Hong Kong Monetary Authority Joseph Chan Tak-lam, Jacqueline Tsang King-shuen (younger sister of former Chief Executive Donald Tsang Yam-kuen) and other parties, recently announced that it will hold an extraordinary general meeting on October 25 to consider the proposed business combination with Synagistics, a Southeast Asian e-commerce solution platform.
MBMC Express News: First reverse merger under HKEX Chapter 18A in the Hong Kong stock market — Strategic merger between Yiteng Pharma and Jabio BioSciences — A new path for industrial integration and transformation of China's innovative pharmaceutical enterprises
Recently, Jabio BioSciences (06998.HK) released a major transaction announcement, declaring that it will conduct a strategic merger with Yiteng Pharma, a leading domestic comprehensive pharmaceutical enterprise integrating R&D, production and sales capabilities. This merger between Yiteng and Jabio marks the joining of forces of two industry heavyweights in China's pharmaceutical market, promoting the in-depth integration of their resources and technologies, and further enhancing the competitiveness of China's innovative drug R&D and commercialization sectors.
MBMC Quick Report: Hong Kong Exchanges and Clearing and Deloitte are expected to rank among the top four in the global IPO market this year.
Recently, Deloitte China's Capital Markets Services division released a report showing that Hong Kong Exchanges and Clearing Limited (HKEX) is expected to rank among the top four global initial public offering (IPO) markets this year.
MBMC Breaking News: Health 160 has received the filing notice for its Hong Kong IPO, with the planned issuance of no more than 61,452,500 ordinary shares.
According to the new regulations on overseas listing filings for domestic enterprises that took effect on March 31, 2023, when a company chooses to list in Hong Kong via H shares, the former "big and small preliminary approval letters" have become a thing of the past. Enterprises can directly submit their prospectuses for overseas listings, and the "big approval letter" will be replaced by a "filing notice".
MBMC News Flash: The chairman of Guotai Junan Securities will lead the absorption and merger of Haitong Securities, aiming to build a first-class investment bank
According to China Securities Taurus, Guotai Junan recently held an online 2024 half-year performance briefing.
MBMC Breaking News: Guizhiyan Pharmaceutical may go public in the United States via a SPAC
Recently, SPAC company DT Cloud Acquisition (DYCQ) announced that it has signed a non-binding letter of intent with Shanghai Maius Pharmaceutical Technology Co., Ltd. (Shanghai Gui Zhiyan Pharmaceutical Technology Co., Ltd., hereinafter referred to as "Gui Zhiyan Pharmaceutical") to conduct a business combination.
MBMC Quick Report: Why is there a lock-up period during an IPO (Initial Public Offering)? And how long is the lock-up period generally?
An Initial Public Offering (IPO) lock-up period is a contractual provision that prohibits insiders who already hold shares from selling their stocks for a certain period of time after the IPO. While the lock-up period varies depending on specific circumstances, it is usually 180 days.
MBMC Breaking News: Brain Aurora has passed the Hong Kong Stock Exchange listing hearing, aiming to become "China's first digital therapy listed stock", focusing on the field of digital therapy for cognitive disorders.
According to recent news from the Hong Kong Stock Exchange, Brain Aurora Medical Technology Co., Ltd. has passed the listing hearing for the Main Board of the Hong Kong Stock Exchange, with China International Capital Corporation Limited and SPDB International Holdings Limited acting as joint sponsors.